Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 1,4-Dioxane | HCID 31275 | — |
| Reactant | Methanesulfonamide | HCID 72879 | — |
| Reactant | 1,8-Diazabicyclo(5.4.0)undec-7-ene | HCID 81184 | — |
| Reactant | Tri-tert-butylphosphine tetrafluoroborate | HCID 2734635 | — |
| Reactant | HCID 66667687 | HCID 66667687 | — |
| Catalyst | trans-Bis(acetato)bis[2-[bis(2-methylphenyl)phosphino]benzyl]dipalladium(II) | HCID 11104995 | — |
| Product | HCID 56644359 | HCID 56644359 | 37% |
Reaction Steps
A solution of 2-(4-bromobenzyloxy)-5-chloropyridine (Preparation 107, 0.12 g, 0.40 mmol), methanesulfonamide (0.10 g, 0.12 mmol), tri-tert-butylphosphonium tetrafluoroborate (12 mg, 0.04 mmol), Herrmann's palladacycle (18 mg, 0.02 mmol) and molybdenehexacarbonyl (105 mg, 0.40 mmol) was stirred in dioxane (2 mL). 1,8-diazabicyclo[5.4.0]undec-7-ene (0.18 mL, 0.12 mmol) was added in one portion, then the vial was sealed and heated in a microwave for 15 minutes at 140° C. The solvent was evaporated in vacuo. The residue was extracted with dichloromethane (30 mL) and washed with water (10 mL). The organic layer was dried over magnesium sulfate, filtered and evaporated. The resulting solid was purified on a 10 g silica cartridge (eluent:dichloromethane, followed by 3% methanol in dichloromethane) to afford the title compound (51 mg, 37%) as a beige solid. This was purified further by preparative HPLC.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09102621B2 |
|---|
| Source dataset | uspto-grants-2015_08 |
|---|
| ORD ID | ord-9f1e221d4ed74e6aa1a70986a59152ae |
|---|
| Source note | uspto-grants-2015_08 |
|---|